Viewing Study NCT00325234


Ignite Creation Date: 2025-12-25 @ 2:25 AM
Ignite Modification Date: 2026-01-24 @ 7:17 AM
Study NCT ID: NCT00325234
Status: COMPLETED
Last Update Posted: 2011-05-20
First Post: 2006-05-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords: